Literature DB >> 17196908

Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain.

Patrice Villars1, Marylin Dodd, Claudia West, Theresa Koetters, Steven M Paul, Karen Schumacher, Debu Tripathy, Peter Koo, Christine Miaskowski.   

Abstract

An understanding of the relationship between the type of analgesic prescription and the prevalence and severity of side effects is crucial in making appropriate treatment decisions. The purposes of this study were to determine if there were differences in the prevalence of side effects among four different types of analgesic prescriptions (i.e., no opioid, only an as needed (PRN) opioid, only an around-the-clock (ATC) opioid, or an ATC+PRN opioid); to determine if there were differences in the severity of side effects among the four prescription groups; and to determine the relationships between the total dose of opioid analgesic medication prescribed and taken and the severity of side effects. As part of a larger study, 174 cancer patients with bone metastasis reported their analgesic use and the prevalence and severity of 11 side effects. Significant differences (P<0.05) were found in prevalence rates for seven of the side effects among the four prescription groups. The highest prevalence rates were found in the only ATC and ATC+PRN groups. Significant differences were found in the severity scores for five of the side effects, with the highest severity scores reported by patients in the only ATC and ATC+PRN groups. Significant positive correlations were found between the severity of six of the side effects and the total dose of opioid prescribed and taken. Risk factors for analgesic-induced side effects are ATC and ATC+PRN prescription types and higher doses of opioid analgesics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17196908      PMCID: PMC1839901          DOI: 10.1016/j.jpainsymman.2006.07.011

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  26 in total

1.  Morphine responses in humans: a retrospective analysis of sex differences.

Authors:  J P Zacny
Journal:  Drug Alcohol Depend       Date:  2001-06-01       Impact factor: 4.492

Review 2.  Gender differences in opioid-mediated analgesia: animal and human studies.

Authors:  B Kest; E Sarton; A Dahan
Journal:  Anesthesiology       Date:  2000-08       Impact factor: 7.892

3.  Ethnicity influences morphine pharmacokinetics and pharmacodynamics.

Authors:  M S Cepeda; J T Farrar; J H Roa; R Boston; Q C Meng; F Ruiz; D B Carr; B L Strom
Journal:  Clin Pharmacol Ther       Date:  2001-10       Impact factor: 6.875

Review 4.  Strategies to manage the adverse effects of oral morphine: an evidence-based report.

Authors:  N Cherny; C Ripamonti; J Pereira; C Davis; M Fallon; H McQuay; S Mercadante; G Pasternak; V Ventafridda
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

5.  Putting cancer pain management regimens into practice at home.

Authors:  Karen L Schumacher; Setsuko Koresawa; Claudia West; Christopher Hawkins; Carol Johnson; Evalyn Wais; Marylin Dodd; Steven M Paul; Debu Tripathy; Peter Koo; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2002-05       Impact factor: 3.612

6.  Pain management autobiographies and reluctance to use opioids for cancer pain management.

Authors:  Karen L Schumacher; Claudia West; Marylin Dodd; Steven M Paul; Debu Tripathy; Peter Koo; Christine A Miaskowski
Journal:  Cancer Nurs       Date:  2002-04       Impact factor: 2.592

7.  Gender differences in narcotic-induced emesis in the ED.

Authors:  Leslie S Zun; La Vonne A Downey; William Gossman; Jason Rosenbaumdagger; Glen Sussman
Journal:  Am J Emerg Med       Date:  2002-05       Impact factor: 2.469

8.  The usefulness of a daily pain management diary for outpatients with cancer-related pain.

Authors:  Karen L Schumacher; Setsuko Koresawa; Claudia West; Marilyn Dodd; Steven M Paul; Debu Tripathy; Peter Koo; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2002-10       Impact factor: 2.172

9.  Sex differences in morphine analgesia: an experimental study in healthy volunteers.

Authors:  E Sarton; E Olofsen; R Romberg; J den Hartigh; B Kest; D Nieuwenhuijs; A Burm; L Teppema; A Dahan
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

Review 10.  The PRO-SELF(c): Pain Control Program--an effective approach for cancer pain management.

Authors:  Claudia M West; Marilyn J Dodd; Steven M Paul; Karen Schumacher; Debu Tripathy; Peter Koo; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2003 Jan-Feb       Impact factor: 2.172

View more
  12 in total

1.  The pediatric PRO-SELF©: pain control program: an effective educational program for parents caring for children at home following tonsillectomy.

Authors:  Kimberly A Sutters; Marilyn C Savedra; Christine Miaskowski
Journal:  J Spec Pediatr Nurs       Date:  2011-08-12       Impact factor: 1.260

Review 2.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

Review 3.  Opioid-induced bowel dysfunction.

Authors:  Gyanprakash A Ketwaroo; Vivian Cheng; Anthony Lembo
Journal:  Curr Gastroenterol Rep       Date:  2013-09

4.  Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.

Authors:  Shiva K Ratuapli; Michael D Crowell; John K DiBaise; Marcelo F Vela; Francisco C Ramirez; George E Burdick; Brian E Lacy; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

5.  Integrative Medicine Therapies for Pain Management in Cancer Patients.

Authors:  Gary Deng
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

Review 6.  Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain.

Authors:  Lieven Annemans
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 7.  The value of acupuncture in cancer care.

Authors:  Weidong Lu; Elizabeth Dean-Clower; Anne Doherty-Gilman; David S Rosenthal
Journal:  Hematol Oncol Clin North Am       Date:  2008-08       Impact factor: 3.722

8.  Endoscopic ultrasound: a powerful tool to modify treatment algorithms in opioid-induced achalasia.

Authors:  Arielle M Lee; Josefin Holmgren; Ryan C Broderick; Joslin N Cheverie; Bryan J Sandler; Garth R Jacobsen; Wilson T Kwong; David C Kunkel; Santiago Horgan
Journal:  Surg Endosc       Date:  2020-08-26       Impact factor: 4.584

Review 9.  Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain.

Authors:  J Devulder; A Jacobs; U Richarz; H Wiggett
Journal:  Br J Anaesth       Date:  2009-09-06       Impact factor: 9.166

10.  Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.

Authors:  Hongyang Wu; Zhendong Chen; Guoping Sun; Kangsheng Gu; Yueyin Pan; Jiqing Hao; Yingying Du; Jie Ning
Journal:  J Exp Clin Cancer Res       Date:  2009-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.